Bio

What If big challenges in drug development could be solved with industry collaborations? What If biopharma thought ''collaborate first''? What If pre-competitive industry collaborations were the norm in every industry? What If de-identified patient-donated data was used over and over again to advance science? A recognized leader and evangelist for global multi-stakeholder collaborations. Broad competencies in late phase drug development, business operations, and financial management. Demonstrated ability to build bridges internally and across multinational organizations to successfully develop and embed collaboration-derived assets. Known as a catalyst and coach for consortia innovation, governance architecture, and solution development and delivery. Excellent connector and judge of talent. Exceptional writing and presentation skills. Experienced non-profit board Director and Chair.